BEHANDLUNG VON HYPERBILIRUBINÄMIE

Patent europeic · EP3851537 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3851537
Numer da la dumonda
EP21151019
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-04-2015
Publitgà
21-07-2021
Concedì
27-12-2023
La protecziun finescha il pli tard
26-04-2035
Proxima taxa annuala scadenta
30-04-2027
Classas IPC
C12N 15/86 (2006.01)
A61K 48/00 (2006.01)
C12N 9/10 (2006.01)
A61K 38/45 (2006.01)
A61P 1/16 (2006.01)
Prioritad
EP 14305622 25.04.2014
EP 14196400 04.12.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2026

    Midada

    Published in Swissreg on 01.05.2026

  2. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  3. 06-11-2024

    Midada

    Published in Swissreg on 06.11.2024

  4. 23-05-2024

    Midada

    Published in Swissreg on 23.05.2024

  5. 27-12-2023

    Concedì

    Published in Swissreg on 27.12.2023

Partidas

Possessur

Genethon

1 bis rue de l'Internationale, 91000 Evry, FR

International Centre for Genetic Engineering and Biotechnology

International Centre For Genetic Engineering And Biotechnology

AREA Science Park Padriciano 99, 34149 Trieste, IT

Inventur

COLLAUD, Fanny

75019 Paris, FR

RONZITTI, Giuseppe

77300 Fontainebleau, FR

MURO, Andrés

34128 Trieste, IT

MINGOZZI, Federico

Philadelphia, Pennsylvania 19118, US

BORTOLUSSI, Giulia

33090 Travesio, IT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.